Trademark

GLYC OBI Trademark Information

Number:
2408882
Words:
GLYC OBI
Images:

Kind:
Figurative
Status group:
REGISTERED
Status code:
Registered
Status detail:
Registered/protected
Priority date:
28 Nov 2023
Lodgement date:
28 Nov 2023
First report date:
23 Jan 2024
Acceptance date:
23 Jan 2024
Acceptance advertised date:
29 Apr 2024
Entered on register date:
08 Jul 2024
Registered from date:
28 Nov 2023
Registration advertised date:
08 Jul 2024
Renewal due date:
28 Nov 2033
Filing date:
28 Nov 2023
Indexing constituents:
GLYC, OBI, O, LTR, =OBI, ENDO, SYME
Class:
5
Mark categories:
Trademark
Registration date:
2024-07-08
Last status check:
2026-06-20 00:08:09
Status updated at:
2026-06-20 00:08:09
Goods and services:
1) Class: 5
Description: Immunostimulants, Chemical preparations for medical purposes, Enzymes for medical purposes, Preparations of microorganisms for medical and veterinary use, Biological preparations for medical purposes, Chemico-pharmaceutical preparations, Chemical preparations for pharmaceutical purposes, Pharmaceutical preparations, Vaccines, Drugs for medical purposes, Adjuvants for medical purposes, Medicines for human purposes, Antioxidant pills, Ferments for pharmaceutical purposes, Enzyme preparations for medical purposes, Anti-cancer drugs, Anti-cancer pharmaceutical preparations, Compounds for treating cancer, Immunotherapeutic agents for cancer, Pharmaceutical preparations for the treatment of cancer
History and publication details:
1) Date: 2024-07-29
Display name: IP Right Registered correspondence sent
2) Date: 2024-07-29
Display name: Application Accepted correspondence sent
3) Date: 2024-07-08
Display name: IP Right Registration Published
4) Date: 2024-07-08
Display name: Status change to Registered/Protected
5) Date: 2024-04-29
Display name: IP Right has been Examined
6) Date: 2024-04-29
Display name: IP Right Acceptance Published
7) Date: 2024-04-05
Display name: Customer Amendment Made correspondence sent
8) Date: 2024-04-05
Display name: Owner name details updated
Description: Owner: OBI PHARMA, INC.
Previous details: Owner: OBI PHARMA, INC.
New details: Owner: OBI PHARMA, INC.
9) Date: 2024-04-02
Display name: Amendment to Amend Owner Requested
10) Date: 2024-04-02
Display name: Amendment to Amend Owner Requested
11) Date: 2024-01-23
Display name: Early Acceptance Notice correspondence sent
12) Date: 2024-01-23
Display name: Status change to Accepted
13) Date: 2023-12-04
Display name: Awaiting examination
14) Date: 2023-12-04
Display name: Word and image indexing completed
15) Date: 2023-11-28
Display name: IP Right Filed correspondence sent
16) Date: 2023-11-28
Display name: IP Right Filed Published
17) Date: 2023-11-28
Display name: Status change to Published
18) Date: 2023-11-28
Display name: Status change to Filed
19) Date: 2023-11-28
Display name: Minimum Filing Requirements Considered
20) Date: 2023-11-28
Display name: Status change to Received
21) Date: 2023-11-28
Display name: Trade mark representation updated
22) Date: 2023-11-28
Display name: Application Received

Owner Information
Owner name:

Owner structured address:
6F., No. 508, Sec. 7 Zhongxiao E. Rd. Nangang Dist. Taipei City 115011, TAIWAN

Owner is private:
0

Service Information
Address Abn:
51665176509

Address name:

Address structured address:
S 6 130 Pendle Way, Pendle Hill, NSW, AUSTRALIA, Postal Code: 2145

Address is private:
0
Scroll to Top